BioSpace News Archive

H.E.L. Group Ltd, a global manufacturer of innovative laboratory tools for process optimization, safety and scale-up, announced the appointment of Louise Madden as Chief Executive Officer (CEO).

Tacalyx announced that it has successfully secured €7 million in seed funding.

Ergomed plc,, a company focused on providing specialised services to the global pharmaceutical industry, announces that Peter George will step down from the Board with immediate effect to focus on his other business activities, in particular Benchmark Holdings plc where he was recently appointed Executive Chairman.

Hutchison China MediTech Limited will showcase data from its proprietary clinical programs at the 2019 European Society for Medical Oncology Congress on September 27 to October 1, 2019 in Barcelona, Spain.

Almac Pharma Services, part of the global contract pharmaceutical development and manufacturing organisation, the Almac Group, has announced the successful completion of three global regulatory GMP inspections across three facilities in the space of just two weeks.

OMO-1 has potential to treat cancer as a monotherapy and in combination with EGFR TKIs for patients becoming resistant to or progressing on treatment

FibroNest cloud-based image analysis tool provides the most advanced phenotypic image analysis and translational platform for the automated quantification of fibrosis and steatosis for NASH and for other fibrotic conditions in drug discovery and drug development projects.

Neuromod Devices Limited announces the closing of an €8 million capital raise, comprised of equity investment and venture-debt.

RaySearch has entered into a long-term distribution agreement with the healthcare industry distribution company Medeqi in Russia.

Wharton Research Data Services, the leading business intelligence, data analytics, and research platform for corporate, academic and government institutions worldwide, is pleased to announce the addition of Preqin private equity data to its offerings.